Forsta Ap Fonden Neurocrine Biosciences Inc Transaction History

Forsta Ap Fonden

$13.7 Billion
Q4 2024

A detailed history of Forsta Ap Fonden transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Forsta Ap Fonden holds 20,200 shares of NBIX stock, worth $3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

20,200

Previous 22,200 9.01%

Holding current value

$3 Million

Previous $2.56 Million 7.91%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$111.62 - $139.44 $223,240 - $278,880	-2,000 Reduced 9.01%	20,200 $2.76 Million
Q3 2024 Oct 24, 2024	SELL	$114.58 - $153.15 $1.19 Million - $1.59 Million	-10,400 Reduced 31.9%	22,200 $2.56 Million
Q2 2024 Aug 08, 2024	SELL	$130.86 - $143.19 $209,376 - $229,104	-1,600 Reduced 4.68%	32,600 $4.49 Million
Q1 2024 May 07, 2024	BUY	$130.4 - $143.74 $2.16 Million - $2.39 Million	16,600 Added 94.32%	34,200 $4.72 Million
Q4 2023 Feb 06, 2024	SELL	$106.07 - $132.76 $63,641 - $79,656	-600 Reduced 3.3%	17,600 $2.32 Million
Q3 2023 Oct 25, 2023	BUY	$94.02 - $117.1 $1.71 Million - $2.13 Million	18,200 New	18,200 $2.05 Million
Q3 2022 Oct 17, 2022	BUY	$92.03 - $107.81 $1.01 Million - $1.19 Million	11,000 Added 423.08%	13,600 $1.44 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $197,054 - $260,181	2,600 New	2,600 $253,000
Q4 2020 Feb 09, 2021	SELL	$86.91 - $108.33 $1.29 Million - $1.61 Million	-14,900 Closed	0 $0
Q3 2020 Feb 19, 2021	BUY	$96.16 - $135.15 $1.43 Million - $2.01 Million	14,900 New	14,900 $1.43 Million
Q3 2020 Oct 22, 2020	SELL	$96.16 - $135.15 $1.17 Million - $1.65 Million	-12,200 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$85.09 - $130.36 $136,144 - $208,576	-1,600 Reduced 11.59%	12,200 $1.49 Million
Q1 2020 May 04, 2020	BUY	$75.11 - $113.76 $1.04 Million - $1.57 Million	13,800 New	13,800 $1.19 Million

Others Institutions Holding NBIX

# of Institutions

634

Shares Held

94.1M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $14.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.

Account